'Female Viagra' is now officially for sale

"Female Viagra" is on the market
(Image credit: iStock)

Addyi, the drug many call "female Viagra," went on sale Saturday, NBC News reports. The FDA rejected Addyi twice — in 2010 and 2013 — before controversially issuing approval to the drug earlier this year.

Flibanserin, as it's known generically, will be prescribed to women to take once daily. Critics have argued the risks associated with the drug's side effects, like low blood pressure and dizziness, can be dangerous, and that the drug hasn't been tested extensively enough. They also say the so-called libido drug may not even be particularly effective for women looking to increase their sex drives.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Julie Kliegman

Julie Kliegman is a freelance writer based in New York. Her work has appeared in BuzzFeed, Vox, Mental Floss, Paste, the Tampa Bay Times and PolitiFact. Her cats can do somersaults.